Inhibikase Therapeutics, Inc. (IKT) Earnings
NASDAQ·Healthcare·Biotechnology
$2.29
+3.39%
Mkt Cap $287.83M
EPS — Estimate vs Actual
Mkt Cap
$287.83M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.54
NASDAQ·Healthcare·Biotechnology
$2.29
+3.39%
Mkt Cap $287.83M
Mkt Cap
$287.83M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.54